These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29108205)

  • 1. [Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China].
    Liang QF; Wang YD; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):760-765. PubMed ID: 29108205
    [No Abstract]   [Full Text] [Related]  

  • 2. Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China.
    Zhang W; Chao S; Chen S; Rao H; Huang R; Wei L; Lok AS
    Dig Dis Sci; 2019 Mar; 64(3):708-717. PubMed ID: 30483909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk.
    Wieland AC; Mettler P; McDermott MT; Crane LA; Cicutto LC; Bambha KM
    J Clin Gastroenterol; 2015 Jan; 49(1):e6-e10. PubMed ID: 24440943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease].
    Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337
    [No Abstract]   [Full Text] [Related]  

  • 5. Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China.
    Chen S; Chao S; Konerman M; Zhang W; Rao H; Wu E; Lin A; Wei L; Lok AS
    Dig Dis Sci; 2019 Dec; 64(12):3480-3488. PubMed ID: 31273595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of heme oxygenase 1 in the diagnosis of non-alcoholic fatty liver disease].
    Yuan XW; Li DD; Liu LD; Zhang Y; Zhao W; Cui LY; Yang Y; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):291-297. PubMed ID: 31082341
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)].
    ; ; ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):748-753. PubMed ID: 31734987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease.
    Katsagoni CN; Papatheodoridis GV; Papageorgiou MV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Fragopoulou E; Kontogianni MD
    Appl Physiol Nutr Metab; 2017 Mar; 42(3):250-256. PubMed ID: 28133993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between metabolism-related chronic disease combination and prevalence of non-alcoholic fatty liver disease in community residents in Shanghai].
    Wang YY; Zhao Q; Chen B; Wang N; Zhang TJ; Jiang YG; Wu YL; He N; Zhao GM; Liu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Jul; 44(7):1106-1113. PubMed ID: 37482714
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiological investigation of fatty liver disease in Northwest China].
    Yan H; Lu X; Gao Y; Luo J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):622-7. PubMed ID: 26447628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study.
    Matthias AT; Fernandopulle ANR; Seneviratne SL
    BMC Res Notes; 2018 Aug; 11(1):556. PubMed ID: 30075812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease is not associated with a lower health perception.
    Mlynarsky L; Schlesinger D; Lotan R; Webb M; Halpern Z; Santo E; Shibolet O; Zelber-Sagi S
    World J Gastroenterol; 2016 May; 22(17):4362-72. PubMed ID: 27158205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China.
    Yan J; Xie W; Ou WN; Zhao H; Wang SY; Wang JH; Wang Q; Yang YY; Feng X; Cheng J
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1654-9. PubMed ID: 23731053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.